Clinical Trial Update: Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 trial evaluating radiotherapy concurrent with apatinib for advanced soft tissue and bone sarcomas of the head and neck.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Head and Neck Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Soft Tissue and Bone Tumor, Head and Neck Cancer | Phase 2 | Status: UNKNOWN